USFDA issues EIR to Piramal Pharma’s USA facility

16 Feb 2023 Evaluate

The United States Food and Drug Administration (USFDA) has issued an Establishment Inspection Report (EIR) for Piramal Pharma’s manufacturing facility located at Lexington (Kentucky, USA). The inspection has now been successfully closed by the USFDA.

Piramal Pharma (PPL) offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries.

Piramal Pharma Share Price

252.60 -9.00 (-3.44%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.